Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.

Activating Notch signaling can kill basal cell carcinoma cells.

Inhibiting PDE8A may help treat hair loss by boosting fat cell growth and hair regeneration.

CD4+ skin cells may be precursors to basal cell carcinoma.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Four specific genes are linked to keloid formation and could be potential treatment targets.

Regulatory T cells protect hair follicle stem cells by maintaining immune privilege in the skin.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

CD19-CAR T cell therapy may help regenerate skin in systemic sclerosis.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

The nodule was a benign cutaneous lymphadenoma, not cancer, and was successfully removed.

KRT80 may worsen cancer by increasing growth and spread, but its full effects on treatment and outcomes need more research.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

The microenvironment affects the behavior and survival of melanocytes with the GNAQ oncogene in melanoma.

UV light helped human hair transplants survive in mice without broad immunosuppression.

Certain substances can help skin cells become anti-inflammatory, aiding in tissue repair.

Dysplastic nevi have unique gene expressions, making them distinct from common melanocytic nevi.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Trichoblastic fibroma and basal cell carcinoma are similar but different from trichoepithelioma.

KY19382 speeds up wound healing by activating a specific cell signaling pathway.

NDRG1 protein helps infantile hemangioma, a common infant tumor, to grow, and its mismanagement by FOXO1 protein plays a big role in causing the tumor.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Targeting specific immune cells may improve treatment for alopecia areata.

Certain immune cells, when activated by specific signals, can encourage hair growth.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

CD200- cells in hair follicles have a higher ability to regenerate hair.

HKN-2 antibody targets specific skin and hair cells, showing keratin complexity.

Nano-Pulse Stimulation™ Therapy is more effective and less damaging than cryoablation for treating melanoma tumors in mice.